192 related articles for article (PubMed ID: 17105367)
1. Forthcoming receptor tyrosine kinase inhibitors.
Choong NW; Cohen EE
Expert Opin Ther Targets; 2006 Dec; 10(6):793-7. PubMed ID: 17105367
[TBL] [Abstract][Full Text] [Related]
2. Receptor Tyrosine Kinase-Targeted Cancer Therapy.
Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinases as targets in cancer therapy - successes and failures.
Traxler P
Expert Opin Ther Targets; 2003 Apr; 7(2):215-34. PubMed ID: 12667099
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
Camorani S; Crescenzi E; Fedele M; Cerchia L
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):263-277. PubMed ID: 29574128
[TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.
Bavcar S; Argyle DJ
Vet Comp Oncol; 2012 Sep; 10(3):163-73. PubMed ID: 22882485
[TBL] [Abstract][Full Text] [Related]
6. [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer].
Leirdal M; Sioud M
Tidsskr Nor Laegeforen; 2002 Jan; 122(2):178-82. PubMed ID: 11873574
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinases as targets for cancer therapy.
Krause DS; Van Etten RA
N Engl J Med; 2005 Jul; 353(2):172-87. PubMed ID: 16014887
[No Abstract] [Full Text] [Related]
8. Inhibitors of tyrosine kinase.
Klohs WD; Fry DW; Kraker AJ
Curr Opin Oncol; 1997 Nov; 9(6):562-8. PubMed ID: 9370078
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment.
Roussidis AE; Karamanos NK
In Vivo; 2002; 16(6):459-69. PubMed ID: 12494890
[TBL] [Abstract][Full Text] [Related]
10. Systematic Analysis of Tyrosine Kinase Inhibitor Response to RET Gatekeeper Mutations in Thyroid Cancer.
Meng S; Wu H; Wang J; Qiu Q
Mol Inform; 2016 Oct; 35(10):495-505. PubMed ID: 27712045
[TBL] [Abstract][Full Text] [Related]
11. [Antineoplastic agents targeting tyrosine kinases].
Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
[TBL] [Abstract][Full Text] [Related]
12. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
13. Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents.
Laird AD; Cherrington JM
Expert Opin Investig Drugs; 2003 Jan; 12(1):51-64. PubMed ID: 12517254
[TBL] [Abstract][Full Text] [Related]
14. The ALK gene, an attractive target for inhibitor development.
Tartari CJ; Scapozza L; Gambacorti-Passerini C
Curr Top Med Chem; 2011; 11(11):1406-19. PubMed ID: 21513493
[TBL] [Abstract][Full Text] [Related]
15. Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib).
Bowles DW; Kessler ER; Jimeno A
Drugs Today (Barc); 2011 Nov; 47(11):857-68. PubMed ID: 22146228
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinases as targets for anticancer therapeutics.
Carlomagno F; Santoro M
Curr Med Chem; 2005; 12(15):1773-81. PubMed ID: 16029146
[TBL] [Abstract][Full Text] [Related]
17. Small molecule tyrosine kinase inhibitors: potential role in pediatric malignant solid tumors.
Rössler J; Geoerger B; Taylor M; Vassal G
Curr Cancer Drug Targets; 2008 Feb; 8(1):76-85. PubMed ID: 18288945
[TBL] [Abstract][Full Text] [Related]
18. Targeting receptor tyrosine kinases in solid tumors.
Zhang J; Hochwald SN
Surg Oncol Clin N Am; 2013 Oct; 22(4):685-703. PubMed ID: 24012395
[TBL] [Abstract][Full Text] [Related]
19. ROS receptor tyrosine kinase: a new potential target for anticancer drugs.
El-Deeb IM; Yoo KH; Lee SH
Med Res Rev; 2011 Sep; 31(5):794-818. PubMed ID: 20687158
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of the class 1 receptor tyrosine kinase family.
Cockerill GS; Lackey KE
Curr Top Med Chem; 2002 Sep; 2(9):1001-10. PubMed ID: 12171567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
